未登录

S

Saman Bahrambeigi

Urmia University of Medical Sciences

H指数:7

被引数:277

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+/AMPK/NF-kB in mice (vol 392, pg 633, 2019)

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2024-05-070

OA

Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-04-0142

PREAI

Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy

IMMUNOLOGY LETTERS

IF2.8

2020-04-0118

PREAI

Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability

阻碍免疫系统防御肿瘤细胞的主要基本因素: 先天免疫反应，代谢和神经递质不足与效应免疫细胞功能障碍之间的联系

IMMUNOLOGY LETTERS

IF2.8

2019-08-0111

PREAI

Polyelectrolyte Carboxymethyl Cellulose for Enhanced Delivery of Doxorubicin in MCF7 Breast Cancer Cells: Toxicological Evaluations in Mice Model

PHARMACEUTICAL RESEARCH

IF4.3

2019-03-1812

PREAI

β-Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+/AMPK/NF-kB in mice

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2019-01-2317

PREAI

Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat

RAGE抑制剂FPS-ZM1，缬沙坦及其组合在链脲佐菌素诱导的大鼠糖尿病中减少肾小管损伤

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2019-01-0126

PREAI

Metformin; an old antidiabetic drug with new potentials in bone disorders

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-01-0196

OAAI